Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations.
about
Review of current optical diagnostic techniques for non-muscle-invasive bladder cancerPreclinical studies and prospective clinical applications for bacteria-targeted imaging: the future is brightHexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladderNon-muscle invasive bladder cancer risk stratificationApproaching the optimal transurethral resection of a bladder tumorEmerging endoscopic and photodynamic techniques for bladder cancer detection and surveillanceDynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy.Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance.The origins of urothelial carcinoma.Recent advances in the diagnosis and treatment of bladder cancer.Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancerDiagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancerBest practice in the treatment of nonmuscle invasive bladder cancer.Blue-light cystoscopy in the evaluation of non-muscle-invasive bladder cancerDevelopments in intravesical therapy for non-muscle-invasive bladder cancer.Optical and opto-acoustic interventional imaging.Recent advances in urinary bladder cancer detection.Current strategies in the treatment of non-muscle-invasive bladder cancer.Is photodynamic diagnosis ready for introduction in urological clinical practice?Current intravesical therapy for non-muscle invasive bladder cancer.Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer.Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden.Current Concepts in the Management of Muscle Invasive Bladder Cancer.Audit of cytology of upper urinary tract.Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial.[Quality of care in patients with newly diagnosed bladder cancer: a prospective assessment in northern Germany].[Photodynamic diagnostics of the bladder: current study results].Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-Efficient activation of a visible light-activatable CA4 prodrug through intermolecular photo-unclick chemistry in mitochondria.Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study.Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?The quality of 5-aminolevulinic acid-induced photodynamic diagnosis and transurethral resection of bladder tumors: does the urologist play a role?.UBC® Rapid Test for detection of carcinoma in situ for bladder cancer.
P2860
Q26739731-D479F382-9280-4670-B5B4-856B4424376EQ26741884-9DAC4538-890B-4963-9FEB-886FCC8AEACBQ26775775-FCE78333-C012-4DA1-909F-E0CC326FAB4FQ26775984-EEF130F1-0E3E-4091-8AB5-32F0CD47DA6EQ26829828-23039DB6-5CEF-4B31-A312-917C64034D70Q27014754-59E71A58-D36B-402F-B922-2D3A8388B416Q33907648-CA54EBA4-138E-4EF3-BFE6-60A22BBBD6D9Q34075838-F4A553AA-BFB8-415D-AE45-7F9DA207196CQ34121078-8940E091-7A40-4075-9C47-130A1AEE7177Q34552725-EEC83DBE-AE2A-407E-A255-D1819EF30AC7Q34838223-55409E43-87BD-4079-9DDD-8235CAB58A3EQ35051551-957AE282-6A9E-436E-A42C-9A4087F793CFQ35688392-A529BCB5-9579-4769-A004-FDEF30FA736DQ37476699-5D2E72EF-34AB-44DA-A6B5-822FE670E553Q37812604-1241A4D8-DC53-4073-91BA-57C2A82EB65CQ37974089-6B56509D-9919-4612-83EC-932AC71407BAQ38030593-39FEC84D-117F-4A4A-9CCC-C609BCB7D1DFQ38048823-CF8C7BBE-8FD7-4BAC-9791-9FE48DAED668Q38114946-1755AECE-6FDB-4DAF-8FF3-1EAD0A08D013Q38129947-08B78AD7-20FF-41D2-B904-3724F2FDE163Q38163897-D2D9B008-7922-449A-B928-5FBE15A482C0Q38895384-DCD27A31-887C-4A5A-9B70-49A3E43D0788Q39105784-87C279AC-7ABA-468E-9F2A-AA7B3BA28194Q39967821-B1BDB1BD-13AB-4E7F-881F-3AB28208BB4FQ43485839-FD22087A-C4E5-4F21-A8FE-C78BD7545417Q44701036-560B7E23-B3B3-4ABA-914B-5137255F0C2EQ45002276-A233130D-EDC7-4AA0-9D99-B29C2F1C5377Q45840112-89580674-E1CB-4A7D-8774-53A412C73CB7Q48860600-2A2AE0DD-1100-43F5-9772-4A3C47AE2DB1Q50219456-5091062E-8CC2-41A5-AE47-9F9FE4717A51Q50244464-5CB3E193-CF7F-4F28-9320-18048AE90FC1Q50275555-3CD1E214-F4CB-4ED0-A25D-1AF08D1DB0BDQ50784569-5DF36A09-0CF1-4842-BBAF-CFB49594598AQ51022257-EF8AFFED-AA18-4C18-A3EE-085AC65565CA
P2860
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hexaminolevulinate-guided fluo ...... evidence and recommendations.
@en
Hexaminolevulinate-guided fluo ...... evidence and recommendations.
@nl
type
label
Hexaminolevulinate-guided fluo ...... evidence and recommendations.
@en
Hexaminolevulinate-guided fluo ...... evidence and recommendations.
@nl
prefLabel
Hexaminolevulinate-guided fluo ...... evidence and recommendations.
@en
Hexaminolevulinate-guided fluo ...... evidence and recommendations.
@nl
P2093
P1433
P1476
Hexaminolevulinate-guided fluo ...... evidence and recommendations.
@en
P2093
A Hugh Mostafid
Claus Riedl
Didier Jacqmin
Dieter Jocham
Frank Sofras
Giario Conti
Harm C Arentsen
J Alfred Witjes
Juan Palou Redorta
P304
P356
10.1016/J.EURURO.2010.01.025
P407
P577
2010-01-22T00:00:00Z